Crism Therapeutics Corporation (CRTX)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 1,000 | 0 | 915k | 0 | 512k |
営業利益 | -2.41M | -2.04M | -2.12M | -1.98M | -3.09M | -1.59M | -1.65M | -694k |
税引前収入 | -5.77M | -1.15M | -3.31M | -2.33M | -2.67M | -1.27M | -3.01M | -9.65M |
純利益 | -5.77M | -1.15M | -3.31M | -2.33M | -2.67M | -1.21M | -3.01M | -9.65M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1 | -0.2 | -0.5 | -0.3 | -0.2 | -0.1 | -0.2 | -0.7 |
EBIT | -2.41M | -2.04M | -2.12M | -1.87M | -2.78M | -1.59M | -1.65M | -7.7M |
EBITDA | -2.41M | -2.03M | -1.25M | -1.98M | -3.08M | -1.59M | -1.65M | -694k |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約